Bronstein, Gewirtz & Grossman LLC Urges ARS Pharmaceuticals Inc. Investors to Act: Class Action Filed Alleging Investor Harm

A securities class action lawsuit has been filed against ARS Pharmaceuticals (NASDAQ: SPRY) and certain officers, according to investor-rights law firm Bronstein, Gewirtz & Grossman. The notice provides no allegations, damages, financial figures, or operational details, but the litigation represents a potential reputational and legal overhang for the company.